Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3668)
ABEONA THERAPEUTICS INC. (ABEO)
Alland Leila — Director
Shares
11,000
Price
$5.92
Total Value
$65.09K
Shares Held After
162,614
% of Holdings
6.3%
NEKTAR THERAPEUTICS (NKTR)
Zalevsky Jonathan — Chief R&D Officer
Shares
5,681
Price
$70.00
Total Value
$397.67K
Shares Held After
9,756
% of Holdings
36.8%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
3,200
Price
$117.70
Total Value
$376.65K
Shares Held After
244,883
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
6,153
Price
$116.99
Total Value
$719.86K
Shares Held After
248,083
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
7,971
Price
$115.82
Total Value
$923.18K
Shares Held After
254,236
% of Holdings
3.0%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
51,375
Price
$114.77
Total Value
$5.90M
Shares Held After
262,207
% of Holdings
16.4%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,110
Price
$114.19
Total Value
$469.31K
Shares Held After
313,582
% of Holdings
1.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,100
Price
$112.79
Total Value
$124.07K
Shares Held After
317,692
% of Holdings
0.3%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,700
Price
$111.57
Total Value
$189.66K
Shares Held After
318,792
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,500
Price
$110.54
Total Value
$165.81K
Shares Held After
320,492
% of Holdings
0.5%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
28,826
Price
$16.04
Total Value
$462.29K
Shares Held After
139,372
% of Holdings
17.1%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
115,844
Price
$45.50
Total Value
$5.27M
Shares Held After
2,555,877
% of Holdings
4.3%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
17,060
Price
$46.43
Total Value
$792.10K
Shares Held After
25,996
% of Holdings
39.6%
uniQure N.V. (QURE)
Kaye Jack — Director
Shares
4,107
Price
$46.49
Total Value
$190.93K
Shares Held After
25,996
% of Holdings
13.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
20,000
Price
$46.40
Total Value
$928.00K
Shares Held After
148,235
% of Holdings
11.9%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
10,000
Price
$46.46
Total Value
$464.60K
Shares Held After
168,235
% of Holdings
5.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,255
Price
$24.98
Total Value
$106.29K
Shares Held After
41,688
% of Holdings
10.2%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,638
Price
$23.88
Total Value
$39.12K
Shares Held After
37,433
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,910
Price
$22.95
Total Value
$43.83K
Shares Held After
35,795
% of Holdings
5.3%
Theravance Biopharma, Inc. (TBPH)
Samaha Eli — 10% Owner
Shares
25,027
Price
$17.13
Total Value
$428.79K
Shares Held After
9,212,252
% of Holdings
0.3%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
30,703
Price
$35.49
Total Value
$1.09M
Shares Held After
93,969
% of Holdings
24.6%
Pharvaris N.V. (PHVS)
Lesage Anne — Chief Early Development
Shares
27,872
Price
$35.48
Total Value
$988.89K
Shares Held After
58,750
% of Holdings
32.2%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
10,833
Price
$16.02
Total Value
$173.59K
Shares Held After
8,961
% of Holdings
54.7%
Contineum Therapeutics, Inc. (CTNM)
Stengone Carmine N. — Director
Shares
10,000
Price
$16.01
Total Value
$160.08K
Shares Held After
17,217
% of Holdings
36.7%
Pharvaris N.V. (PHVS)
Schikan Johannes Gerardus Christiaan Petrus — Director
Shares
30,712
Price
$35.49
Total Value
$1.09M
Shares Held After
315,167
% of Holdings
8.9%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
172
Price
$35.00
Total Value
$6.02K
Shares Held After
55,285
% of Holdings
0.3%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
1,900
Price
$34.84
Total Value
$66.20K
Shares Held After
1,047,205
% of Holdings
0.2%
Beam Therapeutics Inc. (BEAM)
Evans John M. — Director
Shares
23,100
Price
$34.26
Total Value
$791.48K
Shares Held After
1,049,105
% of Holdings
2.2%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
1,000
Price
$9.00
Total Value
$9.00K
Shares Held After
0
% of Holdings
100.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
5,407
Price
$24.50
Total Value
$132.47K
Shares Held After
60,612
% of Holdings
8.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$549.27
Total Value
$131.82K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
14
Price
$546.60
Total Value
$7.65K
Shares Held After
40,753
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
66
Price
$545.96
Total Value
$36.03K
Shares Held After
40,767
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$543.30
Total Value
$239.05K
Shares Held After
40,833
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,081
Price
$542.62
Total Value
$586.57K
Shares Held After
41,273
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,499
Price
$541.60
Total Value
$1.35M
Shares Held After
42,354
% of Holdings
5.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,235
Price
$540.76
Total Value
$1.21M
Shares Held After
44,853
% of Holdings
4.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,309
Price
$539.93
Total Value
$706.77K
Shares Held After
47,088
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
988
Price
$538.51
Total Value
$532.04K
Shares Held After
48,397
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
518
Price
$537.75
Total Value
$278.55K
Shares Held After
49,385
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
110
Price
$536.28
Total Value
$58.99K
Shares Held After
49,903
% of Holdings
0.2%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
2,436
Price
$1.93
Total Value
$4.70K
Shares Held After
14,394
% of Holdings
16.9%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,000
Price
$43.15
Total Value
$43.15K
Shares Held After
149,914
% of Holdings
0.7%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,308
Price
$42.17
Total Value
$139.51K
Shares Held After
150,914
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
3,792
Price
$41.39
Total Value
$156.96K
Shares Held After
154,222
% of Holdings
2.4%
Rapport Therapeutics, Inc. (RAPP)
Gault Cheryl — Chief Operating Officer
Shares
1,900
Price
$40.09
Total Value
$76.17K
Shares Held After
158,014
% of Holdings
1.2%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
2,531
Price
$1.93
Total Value
$4.88K
Shares Held After
21,729
% of Holdings
11.6%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
3,277
Price
$1.93
Total Value
$6.32K
Shares Held After
16,689
% of Holdings
19.6%
BioAge Labs, Inc. (BIOA)
Barton Shane — Principal Accounting Officer
Shares
20,216
Price
$25.19
Total Value
$509.18K
Shares Held After
0
% of Holdings
100.0%
Showing 1–50 of 3668 transactions (page 1 of 74)